UCLA

Division of Endocrinology, Diabetes and Hypertension 

[ Home ] [Contents] [ Forms]

 

[ Faculty_&_Fellows ]

[ The_Endocrine_System ]

[ Gonda_Diabetes_Center ]

[ Fellowship ]

[ Endocrine_Clerkship ]

[ Endocrinology_Resources ]

[ Resources_For_Patients ]

[ Administration ]

 

 

 

 

The Division of Endocrinology, Diabetes, and Hypertension Research Programs

 

The Gonda Diabetes Center, directed by Dr. Andrew Drexler, M.D., located at the 200 UCLA Medical Plaza, Suite 530, is a state-of-the-art facility offering high quality care for patients with diabetes and any other endocrine disorder. 

 

The Hillblom_Islet_Research_Center, directed by Dr. Peter Butler, M.D., located at 900A Weyburn Place North, brings together a group of leading scientists to work as a team in the area of islet research. The team includes experts in the understanding of why islet cells are killed and how this outcome might be avoided, how islet cells are formed and how we might encourage islet repair, how islet cells make and release insulin, and how this process might be increased to restore insulin levels. In the Hillblom Islet Research Center, collaborating investigators have the benefit of conducting their research with state-of-the-art equipment and facilities. This superb environment was made possible by a grant from the Larry L. Hillblom Foundation. The research team in the Islet Research Center strives to provide excellent training for young scientists from around the world, and in so doing, to understand the cause of islet cell destruction leading to diabetes and to understand how islet cells can be replaced that eventually will lead to the prevention and cure of diabetes. 

 

The Blood Brain Barrier Research Laboratory, directed by Dr. William Pardridge, Ph.D., located at 900 Weyburn Place North, Suite 13-164 Warren Hall, focuses on the biological basis of targeted delivery through the blood-brain barrier (BBB) of protein and gene therapeutics. Progress in this difficult area requires the merger of animal neurophysiology, pharmacokinetics, and molecular biology. The laboratory is developing new approaches for the treatment of stroke with neurotrophins, new approaches to imaging gene expression in vivo with antisense radiopharmaceuticals, new approaches to the non-invasive, non-viral targeting of gene medicines to the brain, genetic engineering and "humanization" of monoclonal antibodies, and "BBB genomics", or the discovery of novel genes selectively expressed at the BBB.

 

 

 

Contact information for suggestions or comments about our website or its contents. 

 

Postal Address:

Division of Endocrinology, Diabetes and Hypertension

UCLA Department of Medicine

24-130 Warren Hall

900 Veteran Avenue

Los Angeles, CA 90095-7073

 

Telephone: (310) 794-7555

Fax: (310) 794-7654

Email: ffabunan@mednet.ucla.edu